STOCK TITAN

ESCT - $ESCT STOCK NEWS

Welcome to our dedicated page for ESCT news (Ticker: $ESCT), a resource for investors and traders seeking the latest updates and insights on ESCT stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ESCT's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ESCT's position in the market.

Rhea-AI Summary
Bruker Corporation (BRKR) reports strong Q4 2023 revenues of $854.5 million, up 20.6% yoy, with organic revenue growth of 15.9%. GAAP EPS of $1.41, including a gain on PhenomeX acquisition. Full year 2023 revenues of $2.96 billion, up 17.1% yoy, with organic growth of 14.5%. FY 2023 non-GAAP EPS up 10.3% yoy. Bruker expects 2024 revenue growth of 8% to 10% yoy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.77%
Tags
-
Rhea-AI Summary
Bruker Corporation reports Q3 2023 revenues of $742.8 million, up 16.3% YoY. Organic revenue growth is 10.9% YoY. Q3 2023 GAAP EPS is $0.60, non-GAAP EPS is $0.74, up 12.1% YoY. FY 2023 revenue guidance increased to $2.88-$2.91 billion, implying reported revenue growth of 14%-15% YoY and organic revenue growth of 11.5%-12.5% YoY.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.05%
Tags
-
Rhea-AI Summary
Bruker Corporation reports Q2 2023 revenues of $681.9 million, up 15.9% YoY. Non-GAAP EPS increases by 11.1% YoY. FY 2023 revenue guidance raised to $2.85-$2.90 billion, implying growth of 12.5%-14.5%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.83%
Tags
Rhea-AI Summary
Bruker Corporation announces Q1 2023 revenues of $685.3 million, up 15.2% YoY, with organic revenue growth of 17.6% YoY. GAAP EPS is $0.52 and non-GAAP EPS is $0.64, up 30.6% YoY. FY 2023 revenue guidance increased to $2.83-$2.88 billion, implying 12%-14% growth and organic revenue growth of 9%-11% YoY. Non-GAAP EPS guidance raised to $2.55-$2.60, representing 9%-11% YoY growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.68%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.33%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.69%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.11%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.14%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.26%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.45%
Tags
ESCT

Nasdaq:ESCT

ESCT Rankings

ESCT Stock Data

0
Analytical Laboratory Instrument Manufacturing
Manufacturing